Brazilian healthtech Adros raises pre-seed at R$10M valuation

What's the deal? AdrosDealroom has a profile for this one. Try Dealroom →, a Brazilian healthtech startup building a CRM platform for clinics, laboratories, and medical offices, has raised a pre-seed round at a valuation of R$10 million (Brazilian reais). The company was founded by André Barros, a 22-year-old entrepreneur whose father, Sylvio de Barros, founded WebmotorsDealroom has a profile for this one. Try Dealroom → — one of Brazil's largest automotive marketplaces.

The round was backed by a group of Brazilian angel investors including Marcelo LacerdaDealroom has a profile for this one. Try Dealroom →, Lucas MoraesDealroom has a profile for this one. Try Dealroom → (founder of Olivia AI and board member at Votorantim), Carlos Ambrosio, Fernando Ortenblad, Marcelo Peano, and Renata Porto.

Why now? Brazil's fragmented healthcare market — with thousands of independent clinics and labs — still relies heavily on manual processes and generic software. Purpose-built CRM tools tailored to healthcare providers represent a growing opportunity as the sector digitises.

What could go wrong? Healthcare CRM is a crowded space globally, and Adros will need to prove it can differentiate against both local competitors and international platforms expanding into Latin America. Selling to small and mid-sized clinics also means navigating long sales cycles and tight budgets.

The signal: The deal reflects continued investor appetite for vertical SaaS plays in Latin America's healthcare sector. A pre-seed round anchored by well-connected angels — with ties to fintech and major conglomerates — suggests confidence in the founder's pedigree and the market opportunity ahead.

Read more: Startup Researcher